『Inside Precision Medicine Podcasts』のカバーアート

Inside Precision Medicine Podcasts

Inside Precision Medicine Podcasts

著者： Kathryn Ryan
無料で聴く

このコンテンツについて

 Hosted by Damian Doherty, Editor in Chief of Inside Precision Medicine, Inside Precision Medicine Podcasts bring you the latest conversation, insight, and education from the world of precision medicine.

Hosted on Acast. See acast.com/privacy for more information.

Kathryn Ryan 生物科学 科学
エピソード
  • Epigenetics in the Multi-Omic Era: Predicting Alzheimer’s Before It Starts

    Epigenetics in the Multi-Omic Era: Predicting Alzheimer’s Before It Starts
    2025/12/15

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    45 分
  • Transforming Breast Cancer Screening: Lessons from a Landmark Colombian Study

    Transforming Breast Cancer Screening: Lessons from a Landmark Colombian Study
    2025/12/04

    This podcast features George Busby discussing his work on polygenic risk scores (PRS) and their expanding role in precision medicine. He reflects on how he became interested in PRS, recent advances in methylation risk scores (MRS), and the potential of integrating PRS and MRS to improve disease prediction. The conversation highlights his breast cancer study in Colombian women, exploring its hypothesis, findings, and global relevance. Busby also addresses challenges in translating genomic research into clinical practice, efforts to enhance predictive models, and how technological evolution continues to drive innovation and future directions in genomic medicine.



    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    51 分
  • Methylation Matters: A New Era in Cardiovascular Risk Prediction

    Methylation Matters: A New Era in Cardiovascular Risk Prediction
    2025/11/10
    This Inside Precision Medicine podcast explores how advances in DNA methylation research are transforming diabetes care. The discussion with Charlotte Ling covers motivations for focusing on methylation as valuable prognosticator of disease, the advantages of methylation risk scores (MRS) compared to polygenic risk scores (PRS), and novel gene associations linked to cardiovascular complications in diabetes. She articulates the validation needs across diverse populations, the influence of lifestyle on methylation stability, and strategies for translating these biomarkers into clinical tools. Finally, she reflects on evolving technologies, future applications of methylation biomarkers, and the potential for precision diagnostics and targeted interventions in high-risk diabetic patients.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    43 分
まだレビューはありません